Clinical Trials Directory

Trials / Completed

CompletedNCT03224520

Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions

Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,487 (actual)
Sponsor
University of Massachusetts, Worcester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The research study, "Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions" will test two smoker-driven, social marketing innovations to recruit and engage smokers in Decide2Quit.org (Decide2Quit), which is an evidence-based, effective "Digital Intervention for Smoking Cessation".

Detailed description

S2S has many innovations that are designed to utilize the power of peers and social networks for dissemination. These include: Peer recruitment: Tools to facilitate smokers' recruiting their peers to increase Decide2Quit access; and a recommender computer tailored health communication (recommender CTHC): a Complex machine learning algorithm (recommender systems) that uses smokers' feedback (explicit and implicit) in the current and prior studies to adapt its selection of messages to smokers. Using a 2×2 factorial design, the study will compare individually and collectively the enhancements (recruitment, use, and effectiveness) offered by the S2S functions over the standard version of Decide2Quit (online recruitment and standard CTHC), an active comparison group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRecommender CTHCEnhanced Messaging
BEHAVIORALStandard CTHCStandard Messaging
OTHERPeer RecruitmentTools to facilitate smokers' recruiting their peers
OTHERStandard Online RecruitmentSearch Engine and Social Media Advertisements

Timeline

Start date
2017-12-20
Primary completion
2019-11-01
Completion
2020-03-13
First posted
2017-07-21
Last updated
2021-03-26
Results posted
2021-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03224520. Inclusion in this directory is not an endorsement.